EUROCELL PLC — Director's Dealing 2026

May 1, 2026

National Storage Mechanism | Additional information

RNS Number : 6876C

Eurocell plc

01 May 2026

01 May 2026

EUROCELL PLC

(the "Company")

Director/PDMR Shareholding

Eurocell plc (the "Company") announces that, on 30 April 2026, options were granted under the Eurocell plc Performance Share Plan 2025 to Will Truman, Chief Executive Officer.

The notification set out below, made in accordance with the requirements of the UK Market Abuse Regulation, provides further details.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Name

William Truman

2.

Reason for the notification

a)

Position / status

PDMR (Chief Executive Officer)

b)

Initial notification / amendment

Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Eurocell plc

b)

Legal Entity Identifier

213800RH62IQ7S9OFQ55

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Ordinary shares of £0.001 each in the Company ("Ordinary Shares")

ISIN Number GB00BVV2KN49

b)

Nature of the transaction

Grant of a nil-cost option to acquire ordinary shares under the Eurocell plc Performance Share Plan 2025

c)

Price(s) and volume(s)

Price(s)	Volume(s)
£nil (option price)	830,353

d)

Aggregated information

-     Aggregated volume

-     Aggregated price

-     Aggregated total

N/A - single transaction

e)

Date of the transaction

30 April 2026

f)

Place of the transaction

Outside a trading venue

Enquiries:

Eurocell plc

Vicky Williams

Group Company Secretary

Tel: 01773 842100

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHWPUACCUPQGMU